企業プロフィール
Cybin 株価・ニュース・カタリスト
- ティッカー:
- CYBN
- 取引所:
- AMEX
- セクター:
- Biopharma
- 所在地:
- Canada and listed in the U
株価変動の要因
Current closing-price context is not available for CYBN.
企業概要
事業概要
Cybin is a biotechnology company focused on psychedelic-inspired mental health therapeutics. Its story is built around developing new treatments for depression and other psychiatric conditions through psychedelic-derived science.
所在地とセクター分類
Cybin is headquartered in Canada and listed in the U.S. market. It sits in neuroscience biotechnology with a novel-therapeutics profile.
ビジネスモデルの特徴
The company depends on clinical validation, regulatory progress, and the ability to translate a new therapeutic paradigm into real-world value. Investors usually watch early data, trial design, and capital runway.
バイオ業界での位置付け
Cybin occupies a speculative but highly visible neuroscience niche within biotech. The stock is sensitive to whether psychedelic-inspired therapy can turn into a durable clinical category.
今後のカタリスト
- Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment. The company is still highly dependent on proof of concept.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。